Skip to content

Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI

Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With Alzheimer Dementia and Traumatic Brain Injury (NeuroNS) Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03734289
Enrollment
88
Registered
2018-11-07
Start date
2017-02-01
Completion date
2021-08-31
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Traumatic Brain Injury

Brief summary

To reduce care resistant behaviors (CRB) among people with dementia residing in nursing homes, to a distance-learning education, training, and coaching program for family caregivers of people with dementia or TBI; assess the efficacy of the intervention for reducing frequency or severity of CRB-triggered symptoms of agitation, aggression, and irritability; assess the efficacy of the intervention for improving quality of life of patients, caregivers, and families; and determine how patient and caregiver characteristics influence the effectiveness of the intervention. 5\. Evaluate how the intervention affects the health care costs of people with dementia or TBI.

Detailed description

To address the previously unanswered question of whether theoretically-driven caregiver education and coaching in nonpharmacologic approaches to reduce care resistant behaviors as a trigger of behavioral and psychiatric symptoms of dementia (BPSD) and neuropsychiatric symptoms after Traumatic Brain Injury (NPTBI) will improve caregiver burden, quality of life (QOL), and related outcomes of patients with these conditions and their family members. The intervention of interest is the Neurobehavioral Non-Pharmacologic Supportive Strategies for Family Caregivers of Persons with Dementia or TBI (NeuroNS-Care). Behavioral symptoms in dementia and following TBI vary considerably over time, with a tendency toward spontaneous regression to the mean. Additionally, caregivers often develop idiosyncratic strategies in response to adverse behaviors that might be either adaptive or maladaptive. In order to separate the effects of time alone from the effects of the coaching intervention, one group will be randomized to delayed intervention following a 6 week wait time. This will allow the investigative team the opportunity to compare the natural history of the outcome variables in an untrained portion of the sample to the effects of training over a similar time period.

Interventions

Online coaching sessions will occur weekly for 6 weeks. Web-based courses containing instructional materials that deal with preventing and reducing care resistant behavior (CRB) within intimate care (dressing, bathing, toileting) and treatment regimens (medication, therapeutic activities) after the initial study visit. The NeuroNS-Care intervention is an innovative distance-learning , internet based, family caregiver coaching program; one for the caregivers of persons with dementia and one for the caregivers of persons recovering from TBI. It will be delivered using Instructure's Canvas™ web-based platform.

Sponsors

United States Department of Defense
CollaboratorFED
Congressionally Directed Medical Research Programs
CollaboratorFED
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Caregivers will be randomized in a 1:1 ratio for immediate intervention vs. a 6 week delayed intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

50 participants with possible or probable Alzheimer's disease dementia (of all severity stages) as defined by the NIA-Alzheimer's Association 2011 criteria will be enrolled, along with a family (i.e., unpaid) caregiver. A second cohort of 25 participants who have sustained moderate to severe TBI as diagnosed by UAB-TBIMS standards (generally Glasgow Coma Scale score of 12 or less at admission, cranial imaging with evidence of acute intracranial trauma, and/or post-traumatic amnesia duration of greater than 24 hours) ≥6 months prior to study entry (and their caregivers) will be enrolled. Entry is dependent on caregiver ratings on at least one of three behavioral domains of the Neuropsychiatric Inventory (NPI): 1) Agitation/Aggression, 2) Disinhibition, 3) Irritability /Lability. Based on standard scoring of the NPI, the caregiver must report all of these for at least one domain: * Frequency of Often (several times per week but less than every day) or more, * Severity of Moderate (stressful and upsetting; may require specific management) or higher * Distress of Moderate (fairly distressing, not always easy to cope with) or higher The caregiver must also report that the adverse behavior is triggered by resistance to care-related activities, e.g., bathing, taking medications, attending health-care appointments, etc. Additional inclusion criteria. * Age ranges AD: ≥ 50 years; TBI ≥ 19; Caregiver ≥18 * Sex distribution: both men and women. * Race: any. * Health: generally healthy and ambulatory or ambulatory-aided (i.e., walker or cane). Vision and hearing (hearing aid permissible) sufficient for compliance with testing procedures, or participants who per clinician criteria are deemed eligible to participate in the study. . * Cognitive function and spoken/written English language skills sufficient to provide valid results on neuropsychological testing, or participants who per clinician criteria are deemed eligible to participate in the study. * Concomitant medications: Subjects may be on stable doses of any psycho-active agents for ≥30 days prior to screening and randomization. * Caregiver: unpaid person who provides support or supervision for at least 1 instrumental activity of daily living for the affected person, with direct contact averaging ≥5 of every 7 days, and ≥21 hours weekly. * Access to high-speed/broad band internet service through home computer capable of operating Go-to-Meeting or equivalent conferencing software.

Exclusion criteria

. * Absence of a reliable caregiver who is willing to participate and comply with protocol responsibilities (described below). * Evidence of other psychiatric/neurologic disorders sufficient to be the primary source of cognitive impairment (i.e., stroke, idiopathic Parkinson's disease, schizophrenia, bipolar or unipolar depression, seizure disorder). * Psychotic features (delusions or hallucinations) not adequately treated or not on stable medical therapy for these conditions 30 days prior to enrollment. * Current or recent (within the past 2 years) history of alcoholism or drug misuse. * Subject and/or caregivers who are unwilling or unable to fulfill the requirements of the study. * Any condition which would make the subject or the caregiver, in the opinion of the investigator, unsuitable for the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Zarit Burden InterviewChange from baseline to 6-month follow-upA measure of caregiver burden

Secondary

MeasureTime frameDescription
Change in Dementia Quality of Life (DEMQOL/DEMQOL proxy)Change from baseline through 6-month follow-upMeasures of quality of life for the person with dementia
Change in Neuropsychiatric InventoryChange from baseline through 6-month follow-upMeasure of behavioral symptomsand caregiver distress
Change in Family Quality of Life (Dementia or TBI versions)Change from baseline through 6-month follow-upMeasures of family function and family-based quality of life
Change in Connor-Davidson Resilience Scale (CD-RISC)Change from baseline through 6-month follow-upMeasure of caregiver resilience

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026